Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock?Zacks Investment Research • 04/10/25
Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal MelanomaBusiness Wire • 04/09/25
Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High?Zacks Investment Research • 03/26/25
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual ConferenceBusiness Wire • 03/24/25
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 03/14/25
Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue EstimatesZacks Investment Research • 03/06/25
Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal MelanomaBusiness Wire • 02/14/25
Are You Looking for a Top Momentum Pick? Why Delcath Systems, Inc. (DCTH) is a Great ChoiceZacks Investment Research • 02/10/25
Wall Street Analysts Think Delcath Systems (DCTH) Could Surge 33.74%: Read This Before Placing a BetZacks Investment Research • 02/06/25
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 01/30/25
Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceBusiness Wire • 01/28/25
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial ResultsBusiness Wire • 01/13/25
Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant ExercisesBusiness Wire • 12/30/24
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal CancerBusiness Wire • 12/02/24
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 96.84%: Here's is How to TradeZacks Investment Research • 11/05/24